Stock Taper
EARNINGS CALL ARCHIVE 1 CALL ON FILE
ABUS — Arbutus Biopharma Corp
NASDAQ
FULL STOCK PAGE →

Q3 2024 Earnings Call Summary

NOV 6, 2024
REVENUE
$1.3M -22.4%
NET MARGIN
-1472.5% -325.6 PTS
EPS
-$0.10 +9.1%
FREE CASH FLOW
-$20.7M -43.0%

No summary has been written for this call yet.